Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

5.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K
Conjugated Proteins02:50

Conjugated Proteins

24.6K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
24.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

724
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
724

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The mechanismĀ of promoting rhizosphere nutrient turnover for arbuscular mycorrhizal fungi attributes to recruited functional bacterial assembly.

Molecular ecologyĀ·2023
Same author

Digestion, absorption, and transport properties of soy-fermented douchi hypoglycemic peptides VY and SFLLR under simulated gastrointestinal digestion and Caco-2 cell monolayers.

Food research international (Ottawa, Ont.)Ā·2023
Same author

Recombinant Protein Expression Chassis Library of <i>Vibrio natriegens</i> by Fine-Tuning the Expression of T7 RNA Polymerase.

ACS synthetic biologyĀ·2023
Same author

Continuous fixation of dissolved arsenite from flooded soil by cooperating ferrihydrite with Geobacter sulfurreducens.

ChemosphereĀ·2023
Same author

Purification of Extracellular Protease from <i>Staphylococcus simulans</i> QB7and Its Ability in Generating Antioxidant and Anti-inflammatory Peptides from Meat Proteins.

NutrientsĀ·2023
Same author

Preparation of Carborane-Tailored Covalent Organic Frameworks by a Postsynthetic Modification Strategy as a Barrier to Polysulfide in Lithium-Sulfur Batteries.

ACS applied materials & interfacesĀ·2023

Related Experiment Video

Updated: Dec 4, 2025

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.2K

Translating bioactive peptides for COVID-19 therapy.

Khushwant S Bhullar1, Steven J Drews2, Jianping Wu3

  • 1Department of Agricultural, Food & Nutritional Science, University of Alberta, Edmonton, Alberta, T6G 2P5, Canada; Department of Pharmacology, University of Alberta, Edmonton, Alberta, T6G 2P5, Canada.

European Journal of Pharmacology
|October 25, 2020
PubMed
Summary

Bioactive peptides show promise for combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These molecules target key viral mechanisms, offering a potential new therapeutic avenue against COVID-19.

Keywords:
ACE2Angiotensin IICOVID-19FurinPeptidesSARS-CoV-2

More Related Videos

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.7K

Related Experiment Videos

Last Updated: Dec 4, 2025

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.2K
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
10:16

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

3.6K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.7K

Area of Science:

  • Virology
  • Biochemistry
  • Drug Discovery

Background:

  • COVID-19, caused by SARS-CoV-2, poses a significant global health and economic threat.
  • There is an urgent need for novel therapeutic agents to combat the ongoing pandemic.
  • Understanding SARS-CoV-2 molecular biology reveals potential targets for antiviral interventions.

Purpose of the Study:

  • To review advances in research and potential applications of bioactive peptides against SARS-CoV-2.
  • To explore the role of bioactive peptides in mitigating viral infection.
  • To identify druggable targets for peptide-based therapeutics.

Main Methods:

  • Review of current scientific literature on bioactive peptides and SARS-CoV-2.
  • Analysis of molecular targets, including TMPRSS2, furin cleavage, and RAAS.
  • Structure-function analysis of potential peptide candidates.

Main Results:

  • Bioactive peptides can target critical SARS-CoV-2 mechanisms like TMPRSS2 inhibition and furin cleavage.
  • Peptides targeting the renin-angiotensin-aldosterone system (RAAS) are also discussed.
  • Multiple bioactive peptides demonstrate potential in vitro and in silico to neutralize the virus.

Conclusions:

  • Bioactive peptides represent a promising class of molecules for developing novel COVID-19 therapeutics.
  • Targeting specific viral and host factors with peptides offers a viable strategy.
  • Further research and development are warranted to translate peptide potential into clinical applications against SARS-CoV-2 infection.